Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stimulant medications.

L L Greenhill1, J M Halperin, H Abikoff

  • 1Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA. 73766.103@compuserve.com

Journal of the American Academy of Child and Adolescent Psychiatry
|May 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability.

Molecular psychiatry·2017
Same author

Neurobiological models of attention-deficit/hyperactivity disorder: a brief review of the empirical evidence.

CNS spectrums·2008
Same author

Predictors of physical aggression in children with attention-deficit/hyperactivity disorder.

CNS spectrums·2008
Same author

Neurocognitive functioning in adults with attention-deficit/hyperactivity disorder.

CNS spectrums·2008
Same author

ADHD and reading disabilities: a cluster analytic approach for distinguishing subgroups.

Journal of learning disabilities·2004
Same author

Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry·2001
Same journal

Editorial: Intergenerational Benefits of Treating Maternal Depression: Recognizing Externalities.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same journal

Preventing Child Abuse Through a Brief Parenting Intervention: 2.5 Year Outcomes From the Safer Kids Randomized Controlled Trial.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same journal

Reducing Unnecessary Medical Screening for Pediatric Psychiatric Admissions in the Emergency Department: A Quality Improvement Approach to Implementing Choosing Wisely Recommendations.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same journal

Aberrant Brain Topological Properties in Early-Onset and Adult-Onset Schizophrenia: Evidence from First-Episode Drug-Naïve and Medicated Groups.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same journal

Data-Driven Profiles of Youth Executive Function and Their Longitudinal Associations With Externalizing Problems.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same journal

Editorial: In the Service of Our Children.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
See all related articles

Stimulant medications are effective and safe for treating children with attention-deficit/hyperactivity disorder (ADHD) in the short term. Longer-term studies suggest continued safe and effective use up to 24 months.

Area of Science:

  • Pediatric pharmacology
  • Neurodevelopmental disorders

Background:

  • Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
  • Stimulant medications are frequently prescribed for ADHD management.

Purpose of the Study:

  • To assess the short- and long-term safety and efficacy of stimulant medications for treating ADHD in children.

Main Methods:

  • A comprehensive literature search of randomized controlled trials and reviews was performed.
  • Data on adverse events, growth impacts, animal studies (tolerance, sensitization, neurotoxicity, tumorigenicity), and human dopamine transporter occupancy were analyzed.

Main Results:

  • Stimulant treatment demonstrates robust short-term efficacy and a favorable safety profile in children with ADHD.

Related Experiment Videos

  • Limited long-term studies have not found conclusive evidence of harm with careful therapeutic use.

    • Conclusions:

    • Current evidence supports the efficacy and safety of stimulant medications for ADHD treatment in children for studies extending up to 24 months.